Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | |||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2011 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Oxford, GB HQ Dublin, IE Burlington, US | Locations Tucson, US HQ | Locations Montpellier, FR HQ Grabels, FR |
Employees | Employees 1061% decrease | Employees 1220% increase | Employees 614% decrease |
Funding | |||
Total funding raised | Total funding raised $ 19.7m | Total funding raised $ 1.6m | Total funding raised N/A |
Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View company
SurgiMab is a company that develops of intraoperative detection of tumors.
View company